DCF — PALOMAR MEDICAL CENTER ESCONDIDO
Enterprise Value: $5.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$5.2M
Enterprise Value
$-14.9M
PV of Cash Flows
$20.1M
PV of Terminal Value
$32.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $649.4M | $16.2M | 2.0% | $-11.3M | $-10.3M |
| Year 2 | $668.9M | $23.4M | 3.0% | $-6.6M | $-5.5M |
| Year 3 | $689.0M | $30.9M | 4.0% | $-1.6M | $-1.2M |
| Year 4 | $709.7M | $35.4M | 5.0% | $1.0M | $0.7M |
| Year 5 | $730.9M | $38.3M | 5.0% | $2.4M | $1.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $5.2M. Terminal value accounts for 385% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$630.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.019919615807034188
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5